Related Experiment Videos
Primitive neuroectodermal tumors of the chest wall
J Stefanko1, A D Turnbull, L Helson
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York.
Journal of Surgical Oncology
|January 1, 1988
Summary
Primitive neuroectodermal tumors (PNETs) are aggressive small-cell neoplasms. Despite intensive treatment, long-term survival remains poor, highlighting the need for novel therapeutic strategies.
Area of Science:
- Oncology
- Pediatric Oncology
- Cancer Research
Background:
- Primitive neuroectodermal tumors (PNETs) are rare, highly malignant small-cell neoplasms.
- PNETs most commonly originate in the chest wall or paravertebral regions.
Observation:
- A case report details a patient whose PNET was refractory to resection, chemotherapy, and bone marrow transplant.
- Analysis of 11 patients treated between 1975-1985 revealed only one long-term survivor (48 months) despite aggressive multidisciplinary care.
Findings:
- The median survival for 49 published PNET cases was only 9 months.
- Intensive multidisciplinary treatment showed limited efficacy in improving long-term outcomes.
Implications:
- Conservative surgical approaches that minimize disability are recommended.
- Radiotherapy and intensive chemotherapy remain standard options.
- The use of experimental agents in initial PNET therapy warrants consideration.
- The efficacy of autologous marrow transplant for PNET is currently unclear.